Vanberra Signal

PostEra

Curated by Signal

AI based molecular designing software for drug discovery

Overview

AI-based molecular designing software for drug discovery It uses ML technology for designing molecular compounds to aid in the chemical synthesis of the compounds. It also enables the user to explore chemical space and optimize scaffolds of the lead compound, design the synthetic routes. The company also designs and enables users to order chemical compounds.

Key facts

Founded
2019

Business model

Contact

Open roles

1 role
  • Machine Learning Researcher - Agentic Science

    United States · On-site · Internship

More on Vanberra Signal

Members only

Competitors & similar companies

More Life Sciences Technology companies
  • Assistive technology for people with impaired executive functions of the brain

    Life Sciences TechnologyExeter, United Kingdom
  • Hypoglycemia Symptoms Alarm

    Life Sciences TechnologyNorthampton, United Kingdom
  • Offers computational biology services

    Life Sciences TechnologyLiverpool, United Kingdom

About PostEra

What does PostEra do?

AI-based molecular designing software for drug discovery It uses ML technology for designing molecular compounds to aid in the chemical synthesis of the compounds.

Where is PostEra headquartered?

PostEra is headquartered in London, United Kingdom.

When was PostEra founded?

PostEra was founded in 2019.

Which sector is PostEra in?

PostEra operates in Life Sciences Technology.

Who are PostEra's competitors?

Companies similar to PostEra include Brain in Hand, Medpage, and Gemini Biosciences.

Is PostEra hiring?

Yes. PostEra has 1 open role listed on Vanberra Signal.